Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FX2CN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a specific pharmaceutical fulfillment under the agency's broader medical supply procurement framework. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc. executes this delivery order through its position as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain. The company holds a significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. This delivery order for Exparel, a local anesthetic, exemplifies the company's ongoing role in providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FX2CN?
SPE2DB25FX2CN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FX2CN worth?
The government has obligated $25,106 on SPE2DB25FX2CN.
Is contract SPE2DB25FX2CN an order under another contract?
Yes. SPE2DB25FX2CN is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2CN competed?
The extent of competition for SPE2DB25FX2CN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award